Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells

European Journal of Pharmacology

Volumn 319, Issue 1, 1997, Pages 123-130

  Sugawara, Takeshi ^a   Ohta, Toshio ^a   Asano, Tadashi ^a   Ito, Shigeo ^a   Nakazato, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Acetylcholinesterase activity; Adrenal homogenate; Nicotine induced inward current; Patch clamp; Physostigmine

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ADRENALIN; NICOTINE; NORADRENALIN; PHYSOSTIGMINE; TACRINE;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; FEMALE; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; REGIONAL PERFUSION;

ACETYLCHOLINE; ANIMALS; CATECHOLAMINES; CHOLINESTERASE INHIBITORS; CHROMAFFIN CELLS; FEMALE; GUINEA PIGS; MALE; MEMBRANE POTENTIALS; NICOTINE; NICOTINIC ANTAGONISTS; PERFUSION; PHYSOSTIGMINE; TACRINE;

EID: 0031566872     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00835-7     Document Type: Article

References (24)

1. Braga, M.F.M., A.L. Harvey and E.G. Rowan, 1991, Effects of tacrine, velnacrine (HP029), suronacrine (HP128) and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro, Br. J. Pharmacol. 102, 909.
2. Clarke, P.B.S., M. Reuben and H. El-Bizri, 1994, Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum, Br. J. Pharmacol. 111, 695.
3. + current, Eur. J. Pharmacol. 141, 153.
4. Elinder, F., A.K. Mohammed, B. Winblad and P. Arhem, 1989, Effects of THA on ionic currents in myelinated axons of Xenopus laevis, Eur. J. Pharmacol. 164, 599.
5. Ellman, G.L., K.D. Courtney, V. Andres Jr. and R.M. Featherstone, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7, 88.
6. Fabiani, M.E., P. Kabo and O.F. Story, 1992, Prejunctional actions of tacrine on autonomic neuroeffector transmission in rabbit isolated pulmonary artery and rat isolated atria, Clin. Exp. Pharmacol. Physiol. 19, 631.
7. Flynn, D.D. and D.C. Mash, 1989, Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine, J. Pharmacol. Exp. Ther. 250, 573.
8. + channel by tacrine: interactions with muscarinic and adenosine receptors, Eur. J. Pharmacol. 154, 59.
9. Hamill, O.P., A. Marty, E. Neher, B. Sakmann and F.J. Sigworth, 1981, Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches, Pflüg. Arch. 391, 85.
10. Heilbronn, E., 1961, Inhibition of cholinesterases by tetrahydroaminoacridine, Acta Chem. Scand. 15, 1386.
11. Hochman, J. and R.L. Perlman, 1976, Catecholamine secretion by isolated adrenal cells, Biochim. Biophys. Acta 421, 168.
12. Ito, S., Y. Nakazato and A. Ohga, 1979, The effect of veratridine on the release of catecholamines from the perfused adrenal gland, Br. J. Pharmacol. 65, 319.
13. Kelly, K.M., R.A. Gross and R.L. Macdonald, 1991, Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons, Neurosci. Lett. 132, 247.
14. Mizobe, F. and B.G. Livett, 1982, Biphasic effect of eserine and other acetylcholinesterase inhibitors on the nicotinic response to acetylcholine in cultured adrenal chromaffin cells, J. Neurochem. 39, 379.
15. Nielsen, J.A., E.E. Mena, I.H. Williams, M.R. Nocerini and D. Liston, 1989, Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes, Eur. J. Pharmacol. 173, 53.
16. Nilsson, L., A. Adem, J. Hardy, B. Winblad and A. Nordberg, 1987, Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? J. Neural Transm. 70, 357.
17. Osterrieder, W., 1987, 9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels, Br. J. Pharmacol. 92, 521.
18. Perry, E.K., C.J. Smith, J.A. Court, J.R. Bonham, B.M. Rodway and J.R. Atack, 1988, Interaction of 9-amino-1,2,3,4-tetrahydroamino-acridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro, Neurosci. Lett. 91, 211.
19. Rogawski, M.A., 1987, Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons, Eur. J. Pharmacol. 142, 169.
20. Sahakian, B.J., A.M. Owen, N.J. Morant, S.A. Eagger, S. Boddington, L. Crayton, H.A. Crockford, M. Crooks, K. Hill and R. Levy, 1993, Further analysis of the cognitive effects of tetrahydroamino-acridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB, Psychopharmacology 110, 395.
21. Schauf, C.L. and A. Sattin, 1987, Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola, J. Pharmacol. Exp. Ther. 243, 609.
22. Stevens, D.R. and C.W. Cotman, 1987, Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons, Neurosci. Lett. 79, 301.
23. Summers, W.K., L.V. Majovski, G.M. Marsh, K. Tachiki and A. Kling, 1986, Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type, New Engl. J. Med. 315, 1241.
24. Thesleff, S., L.C. Sellin and S. Taggerud, 1990, Tetrahydroamino-acridine (tacrine) stimulates neurosecretion at mammalian motor endplates, Br. J. Pharmacol. 100, 487.